Latest:
Dr Eskander on Interpreting Biomarker Analyses From the DUO-E Trial in pMMR Endometrial Cancer
Ramez N. Eskander, MD, discusses the limitations of biomarker analyses for guiding treatment decisions in pMMR endometrial cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Rami D. Komrokji, MD
Latest:
Dr Komrokji on the Potential Implications of the COMMANDS trial in MDS
Rami Komrokji, MD, shares the potential clinical implications of data from the phase 3 COMMANDS trial of luspatercept in patients with very low– to intermediate-risk myelodysplastic syndromes who have not received prior treatment with an erythropoiesis-stimulating agents.
Rami S. Komrokji, MD
Rami S. Komrokji, MD, is a professor of medicine and Oncologic Sciences at the University of South Florida College of Medicine, and vice chair of the Malignant Hematology Department at Moffitt Cancer Center, n Tampa, FL.
Latest:
Dr Komrokji on the Clinical Integration of Imetelstat for Lower-Risk MDSLR-MDS
Rami Komrokji, MD, shares advice on how to integrate imetelstat into clinical practice for transfusion-dependent lower-risk myelodysplastic syndromes.
Ramona Dadu, MD
Latest:
Dr. Dadu on Treatment Options for Thyroid Cancer
Ramona Dadu, MD, assistant professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment options for patients with anaplastic thyroid cancer.
Ramona Hagmaier, MHS, PA-C
Latest:
Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature
In May 2005, a 25-year-old female presented to her primary care physician complaining of a newly palpable breast mass that had grown to several centimeters over the course of a few months.
Rana R. McKay, MD
Rana R. McKay, MD, FASCO, is a professor in the Department of Medicine and Department of Urology at the University of California, San Diego Health.
Latest:
Final Thoughts: Importance of Treating mCSPC and Preserving Quality of Life
Panelists discuss how successful metastatic castration-sensitive prostate cancer (mCSPC) management requires balancing cancer control with quality-of-life preservation, emphasizing the need for better tools to measure patient-reported outcomes, comprehensive survivorship care addressing cardiovascular and bone health, and personalized approaches that help patients understand their prognosis while maintaining their ability to thrive during treatment.
Randal S. Weber, MD, FACS
Latest:
Dr. Randal Weber on Future Treatment Approaches for Patients With Melanoma
Randal S. Weber, MD, FACS, professor, department chair, John Brooks Williams and Elizabeth Williams Distinguished University Chair in Cancer Medicine, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses future treatment approaches for patients with melanoma.
Randall A. Oyer, MD
Latest:
Dr. Oyer on Tools for Clinicians to Use When Treating Patients With Cancer
Randall A. Oyer, MD, oncology program, medical director, Lancaster General Health, treasurer, Association of Community Cancer Centers, discusses some of the tools clinicians could potentially use for their patients with cancer.
Randy D. Proffitt, MD
Latest:
Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature
In May 2005, a 25-year-old female presented to her primary care physician complaining of a newly palpable breast mass that had grown to several centimeters over the course of a few months.